3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Enrolling by invitation
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Thrombocytopenia
4
Leukemia
3
Myelodysplastic Syndromes
2
Lymphoma
2
Hematologic Diseases
2
Venous Thromboembolism
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Lymphoma, T-Cell
1
Lymphoma, B-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Hematologic Neoplasms
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Cyclophosphamide
14
fludarabine
10
fludarabine phosphate
8
Whole-Body Irradiation
7
thymoglobulin
5
Thiotepa
5
Tacrolimus
5
Stem Cell Transplantation
5
Standard of Care
5
Practice Guidelines as Topic
5
Nivolumab
5
Granulocyte Colony-Stimulating Factor
5
Busulfan
5
Azacitidine
5
venetoclax
4
Radiotherapy
4
Mycophenolic Acid
4
Methotrexate
4
Melphalan
4
Filgrastim
4
Cytarabine
4
Antilymphocyte Serum
4
Rituximab
3
Mesna
3
Leucovorin
3
Dexamethasone
3
Calcium Dobesilate
3
Alemtuzumab
3
ruxolitinib
2
ceritinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Hematologic Neoplasms
×
Platelet Transfusion
×
Clear all
NCT02074436
2022-07-19
PROBLEMA
Emory University
Phase 2
Terminated
29 enrolled
10 charts